rxstat › Classes › Psychostimulants And Nootropics

Psychostimulants And Nootropics: shortage status in Canada

3 of the 6 psychostimulants and nootropics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Atomoxetine (Strattera) Partial shortage 9 of 63 reported products affected · est. return Dec 31, 2030 Methylphenidate (Biphentin) Partial shortage 6 of 60 reported products affected · est. return Nov 15, 2026 Modafinil (Alertec) Partial shortage 1 of 6 reported products affected Dextroamphetamine (Dexedrine Spansule Src) No current shortage Lisdexamfetamine (Vyvanse) No current shortage Mixed Salts Amphetamine (Adderall) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.